Anexo

0 comentarios

*La OMS y la ESPGHAN indica que los niños con diarrea que persiste por más de siete días o los hospitalizados por gastroenteritis aguda severa pueden beneficiarse de una dieta sin lactosa para reducir la duración de la diarrea

**Definición de paraprobiótico: Células microbianas no viables, que cuando se administran en cantidades adecuadas, confieren un beneficio al consumidor humano o animal1

  1. Aurora Lázaro Almarza BMM. Alimentación del lactante sano; Protocolos diagnóstico-terapéuticos de Gastroenterología, Hepatología y Nutrición Pediátrica SEGHNP-AEP.
  2. García EG. Obesidad y síndrome metabólico en pediatría. 2015.
  3. http://www.aecosan.msssi.gob.es/AECOSAN/web/seguridad_alimentaria/subdetalle/alimentos_lactantes.htm.
  4. Estudio comparativo de la leche de mujer con las leches artificiales B. Martín Martíneza. An Pediatr, Monogr. 2005;3(1):43-53
  5. PEDIATRIC REVIEW. Timing of the introduction of complementary feeding and risk of childhood obesity: a systematic review. J Pearce, MA Taylor and SC Langley-Evans. International Journal of Obesity (2013) 37, 1295–1306
  6. Infant formulas with increased concentrations of alfa-lactalbumin. Eric L. Lien. Am. J. Clin Nutr 2003:77 (suppl): 1555s-85s
  7. Alpha-lactalbumin enriched low-protein infant formulas: a comparison to breast-milk feeding. Heine WE, Radke M, Wutzke KD, Peters E, Kundt G. Acta Paeditr 1996; 85:1024-8.)
  8. OMS (Organización Mundial de la Salud) 
  9. Estrategia NAOS (Ministerio de Sanidad y Consumo). 
  10. May 2003 18 Jensen RG, 1995. Hand Book of milk composition. New York, Academic Press.)
  11. Antireflux or Antiregurgitation milk products for infants and young children: A commentary by the ESPGHAN Committee on Nutrition. Journal of pediatric gastroenterology and nutrition 2002; 34: 496-49.
  12. Effect of locust bean gum in anti-regurgitant milk on the regurgitation in uncomplicated gastroesophageal reflux. R. Miyazawa, T. Tomomasa, H. Kaneko and A. Morikawa. JPNG 38:479-483 May 2004.)
  13. The roles of long chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of the current knowledge and consensus recommendations. B. Koleztko, E. Lien, C. Agostini et al. J. Perinat Med 2008; 36 (1): 5-14. 
  14. Neurodevelopmental quotient of healthy term infants at 4 months and feeding practice: the role of long chain polyunsaturated fatty acids. C. Agostini, S. Trijan, R. Bellu, E. Riva, M. Giovanni. Pediatr Res 1995; 38: 262-26.
  15. Essential fatty acids metabolism and its modifi cation in atopic eczema. David F Horrobin. Am J Clin Nutri 2000; 71 (suppl): 367S-72S. frutoofru
  16. Linolenic acid supplementation for prophylaxis of atopic dermatitis – a randomized controlled trial in infants at high familiar risk. C. JAW van Gool, C. Thijs, C. JM Henquet, A. C. van Houwelingen, P. C. Dagnelie, J. Schrander, P.PCA. Menheere and P.A. van den Brant. The Americal Journal of clinical Nutrition. 
  17. Dietary nucleotides: cellular immune, intestinal and hepatic system effects. J. Nutr 1994: 124: 144-8s.
  18. Modulation of the immune system by human milk and infant formula containing nucleotides. Pikering LK, Granoff DM, Erickson JR, Masor ML and cols. American Academy of Pediatrics. 1998; 101: 242-24.  
  19. Nucleotide supplementation and the growth of term small for gestational age infants. Cosgrove M. (1996) Arch Dis Child 74 (f122-f125)1
  20. Alergia alimentaria. Recomendaciones para su prevención. Ferrer Lorente, Nieto García, Dalmau Serra .Acta Pediatr. Esp. 1999; 57: 431-435
  21. Dietary products used in infants for treatment and prevention of food allergy.Joint Statement of the ESPACI and ESPGHAN. A,Host, B Koletzko, S Dreborg,A Muraro, U Wahns, P Aggett, J-L, Bresson, O Hernell, H Lafeber, KF Michaelsen, J-L Micheli, J Rigo, L Weaver, H Heymans, S Strobel, Y Vandenplas Arch Dis Child 1999;81:80-84. 
  22. Feeding Preterm Infants After Hospital Discharge A Commentary by the ESPGHAN Committee on Nutrition ESPGHAN Committee on Nutrition: Peter J. Aggett.
  23. Carlo Agostoni, Irene Axelsson, Mario De Curtis, Olivier Goulet, Olle Hernell, LBerthold Koletzko1, Harry N. Lafeber, Kim F. Michaelsen, John W.L. Puntis, Jacques Rigo, Raanan Shamir, Hania Szajewska, Dominique Turck, and Lawrence T. Weaver. 2. EFSA Panel on Contaminants in the Food Chain (CONTAM). Risks for human health related to the presence of 3- and 2 monochloropropanediol (MCPD), and their fatty acid esters, and glycidyl fatty acid esters in food. EFSA Journal 2016;14(5):4426.
  24. Effects of a low birthweight infant formula containing human milk levels of docosahexaenoic and arachidonic acids. Koletzko, Edenhofer, Lipowsky, Reinhardt.
  25. Dietary nucleotides: cellular immune, intestinal and hepatic system effects. J. Nutr 1994: 124: 144-8s. 
  26. Modulation of the immune system by human milk and infant formula containing nucleotides. Pikering LK, Granoff DM, Erickson JR, Masor ML and cols. American Academy of Pediatrics. 1998; 101: 242-249.
  27. Quantitative assessment of exocrine pancreatic function in infants and children. Hadorn B, Zoppi G, Shmerling DH, Prader A, McIntyre I, Anderson CM.
  28. Delachaume-Salem E, Sarles H. Normal human pancreatic secretion in relation to age. Biol Gastroenterol 1970; 2: 135-46.
  29. Digestibility of starches in infants and children. De Vizia B, Ciccimarra F, De Cicco N, Auricchio S.
  30. CODEX ALIMENTARIUS. DIRECTRICES SOBRE PREPARADOS ALIMENTICIOS COMPLEMENTARIOS PARA LACTANTES DE MÁS EDAD Y NIÑOS PEQUEÑOS CAC/GL 8-1991 Adoptadas en 1991. Enmendadas en 2017. Revisadas en 2013.
  31. “Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial”. Kalliomäki, M., Salminen, S., Arvilommi, H., Kero, P., Koskinen, P., Isolauri, E., The Lancet, Vol 357, April 7, 2001. 
  32. Safety and benefits of FOS as food ingredients. Spiegel JE, Rose R, Karabel P, Frankos VH and Schimitt DF. Food Technology. January 1994: 85-89 
  33. Effects of Fructooligosaccharides on Intestinal Flora and Human Health. Hidaka H. Et al. Bifidobacteria Microflora. 1986, vol.5 (1): 37-50.